James George Robinson - 02 May 2022 Form 4 Insider Report for NYMOX PHARMACEUTICAL CORP (NYMXF)

Role
Director
Signature
/s/ James G. Robinson
Issuer symbol
NYMXF
Transactions as of
02 May 2022
Net transactions value
+$1,900,000
Form type
4
Filing time
06 May 2022, 06:00:47 UTC
Next filing
26 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NYMXF Common Stock Purchase $1,900,000 +1,151,515 +32% $1.65 4,702,065 02 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NYMXF Warrant Purchase $0 +1,151,515 $0.000000 1,151,515 02 May 2022 Common stock 1,151,515 $2.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.